US Patent 9260501 Peptide extended insulins

Patent 9260501 was granted and assigned to Novo Nordisk on February, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novo Nordisk

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9260501

Patent Inventor Names

Jan Markussen0

Thomas Høeg-Jensen0

Thomas Børglum Kjeldsen0

Date of Patent

February 16, 2016

Patent Application Number

12312132

Date Filed

October 29, 2007

Patent Citations Received

‌

US Patent 12059452 Fusion proteins

Patent Primary Examiner

‌

Gyan Chandra

Patent abstract

Insulins to which there is connected an amino acid oligomer have satisfactory properties.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9260501 Peptide extended insulins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API